R. Allikmets et al., Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies, HUM GENET, 104(6), 1999, pp. 449-453
Vitelliform macular dystrophy (VMD2, Best disease, MIM153700) is an early o
nset, autosomal, dominant macular degeneration characterized by the deposit
ion of lipofuscin-like material within and below the retinal pigment epithe
lium (RPE); it is associated with degeneration of the RPE and overlying pho
toreceptors. Recently, we cloned the gene bestrophin, which is responsible
for the disease, and identified a number of causative mutations in families
with VMD2. Here, we report that the analysis of bestrophin in a collection
of 259 age-related macular degeneration (AMD) patients provides evidence t
hat mutations in the Best disease gene do not play a significant role in th
e predisposition of individuals to AMD. However, our results suggest that,
in addition to Best disease, mutations within the bestrophin gene could be
responsible for other forms of maculopathy with phenotypic characteristics
similar to Best disease and for other diseases not included in the VMD cate
gory.